U.K. Panel Seeks $1.5 Billion to Extend Alvey Computer Project

LONDON—Britain needs to spend $1.5 billion on information technology research and applications to extend the results of the Alvey program now underway, according to a new report from a committee of government, academic and university administrators. The so-called IT 86 committee, formed early last year, has recommended $800 million in further research and $700 million for applications programs over an unspecified five-year period. Of the total for research, $75 million would be allocated a

Written byJohn Stansell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The so-called IT 86 committee, formed early last year, has recommended $800 million in further research and $700 million for applications programs over an unspecified five-year period. Of the total for research, $75 million would be allocated among academic researchers. The funds would help to relieve the current financial crisis, especially with respect to new equipment and facilities, facing most universities.

The government should contribute about one-fourth of the total amount to be spent on applications and more than one-half of the total for research, the report explained, with industry supplying the remainder. Its contribution would include continued participation in the Esprit program, a collaborative effort with other members of the European Community on various high-technology projects.

The committee's proposals are designed to ensure that results from the five-year Alvey program, scheduled to end in 1989, are carried forward. Alvey has established several collaborative research programs between uiniversities and industries ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies